NDC 13985-582 - Acepromazine Maleate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-582
- Package NDCs from labels
- 13985-582-25, 13985-582-50
- Manufacturer
- MWI/VetOne
- Effective date
- 2025-03-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acepromazine Maleate - MWI/VetOne | MWI/VetOne | 2025-03-17 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-582-25 | Acepromazine Maleate | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 5 | |
| 13985-582-50 | Acepromazine Maleate | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ACEPROMAZINE MALEATE | ACTIVE INGREDIENT | 37862HP2OM | ACEPROMAZINE MALEATE TABLET [MWI/VETONE] | 1 | |
| ACEPROMAZINE | ACTIVE MOIETY | 54EJ303F0R | ACEPROMAZINE MALEATE TABLET [MWI/VETONE] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 3c5f0f65-8a54-4a55-ad4e-0f0be97631d7 | 2024-09-15 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | LX22YL083G |
| Isolyte P in Dextrose | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | B. Braun Medical Inc. | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 | 2024-06-24 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Lactated Ringers and Dextrose | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | dbed53b7-0109-4561-8342-0178ec8c64b0 | 2024-05-22 | Warnings, Adverse reactions | LX22YL083G |
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 1b912c7e-f005-4af4-b683-083440964249 | 2024-05-22 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 55d9ae37-4553-47e7-a2e3-86b48b5227cd | 2024-05-08 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | f0cc6713-4d47-49be-8116-901c99002b6b | 2024-05-07 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | 97001218-086c-430a-9e0d-6c7031c91d94 | 2024-05-06 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | fe5b5182-c859-4c74-b2e0-467be5b2e329 | 2024-05-06 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | f2379398-a07b-417e-a022-f7b41f962067 | 2024-04-24 | Warnings, Adverse reactions | LX22YL083G |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Dextrose monohydrate | DEXTROSE MONOHYDRATE | HF Acquisition Co LLC, DBA HealthFirst | d7c4f9eb-9b89-c5a3-e053-2a95a90a28a2 | 2024-02-22 | Warnings, Adverse reactions | LX22YL083G |
| 50% DEXTROSE | 50% DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 763b1cb8-1151-5f59-e053-2991aa0a4e01 | 2024-02-22 | Warnings, Adverse reactions | LX22YL083G |
| DEXTROSE | DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 75c902e8-50e7-a337-e053-2991aa0a2093 | 2024-02-19 | Warnings, Adverse reactions | LX22YL083G |
| Heparin Sodium in Dextrose | HEPARIN SODIUM AND DEXTROSE | B. Braun Medical Inc. | 92a6f533-1a3d-4734-b413-d245592454e3 | 2023-07-31 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | 677a81e5-26ba-2a69-e053-2991aa0a101a | 2023-05-30 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | ada63d44-3b37-b65d-e053-2a95a90aa088 | 2023-05-03 | Warnings, Adverse reactions | LX22YL083G |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | International Medication Systems, Limited | fcc7ac79-cd70-4f03-a4de-f051f9ca1f7d | 2022-12-20 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.